BNET Industries
Market Cap:$300.5M
Last Fiscal Year Sales:$91.8M
- Public
Dow Jones Description
Comet Technologies, Inc. (the "Company" or "Comet") is a "blank check" company which has been seeking to locate a business enterprise which it may acquire, merge or reorganize with, or become engaged in. The Company has been inactive for several years, and until January, 2004, when it entered into an agreement with Town House Land Limited, discussed below, had not located any specific business enterprise for its involvement, nor had it entered into any arrangement or agreements with respect thereto. Since the completion of the Company's public offering in August 1986, the Company has reviewed and evaluated numerous business ventures for possible acquisition or participation by the Company. To date, the Company has not acquired any business venture or engaged in any active operations. The Company was inactive until January, 2004, when the Company entered into a Stock Exchange Agreement (the "Exchange Agreement") with Town House Land Limited ("Town House"), a company organized in the Hong Kong Special Administrative Region in The People's Republic of China, and the shareholders of Town House, providing for the acquisition of Town House in a reverse acquisition.
Chief Financial Officer
Han XiaoNumber of Employees 1,804
Contact Information
No. 38 Dingxin 3rd Street
Nangang District, Heilongjiang Province
Harbin 150001
213-488-5131
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
China Sky One Nears Approval on Two Diagnostic Tests
-
Gentium loses CEO, board
News & Analysis
Filter by
china sky one medical inc. and chinabio today - All News and Analysis
China Sky One to Sell Diagnostic Kits in Southeast Asia
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) has signed up Guangdong Mediacy Kind Medical Devices Industry Service Company to be its exclusive sales agent in Southeast Asia for two of the company’s diagnostic kits: AMI Diagnostic Kit, used to diagnose myocardial infarction, and Human Urinary Albumin Elisa...
China Sky One Nears Approval on Two Diagnostic Tests
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) said it expects to have final SFDA approval for two more diagnostic kits by the end of 2009. One is a diagnostic test for Human Prostate Specific Antigen, an indicator of prostate related diseases, and the other is a determination...
China Sky One Expands Patch Distribution into Canada
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) has begun exporting its Pain Relief patch to Canada. Because the product is based on a traditional Chinese herbal formulation, it did not have to undergo clinical trials before going on sale. The company said the first order was for...
China Sky One Admits Under-Reported Revenue
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) (??????????) admitted that its financial reports filed with the State Administration for Industry and Commerce (SAIC) under-reported the income of China Sky One’s China-based subsidiaries. The company said it expects the SAIC to assess a penalty for the misstatements, but...
China Sky One Reports Record Results for Q2
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported record high results for Q2 of 2009, and the company reiterated its guidance for full-year 2009. During the second quarter, revenue climbed 36% to $32.2 million, while net income rose 17% to $9.5 million, or 57 cents per share,...
China Sky One May Raise New Capital for Acquisitions
ChinaBio Today submits: China Sky One Medical Inc, (NSDQ: CSKI) is considering raising funds to finance acquisitions. The company’s primary goal will be to acquire new products, instead of whole brands or entire companies, according to CEO Liu Yanqing who was quoted in a Reuters article. Liu said...
China Sky One Wins Good Manufacturing Practices Renewal
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported that its new Peng Lai Jin Chuang Pharmaceutical Company subsidiary received an SFDA renewal of its Good Manufacturing Practices Certificate. The certificate is good for five years.China Sky One closed its purchase of Jin Chuang in September 2008. For...
China Sky One Receives Seventh New Product Approval for 2009
ChinaBio Today submits: China Sky One Medical CSKI was given approval by the SFDA to produce Diclofenac Sodium eye drops. The new product will be used to treat eye conditions including uveitis, keratitis and sclerotitis. Diclofenac Sodium eye drops are able to inhibit formation of unwanted blood vessels in...
China Sky One Expands Portfolio with Two New Drugs
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) announced further additions to its ever-larger portfolio of pharmaceutical products. The company reported the SFDA approved production of two new drugs, bringing to 25 the total number of approvals for China Sky One Medical since January 2008. Another 20 products...
China Sky One Seals Novel Cancer Drug Deal
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) has begun a $10 million cooperative effort with Taiwan Golden Biotechnology Corporation to develop a novel cancer drug, Antroquinonol. The drug is a stronger version of a TCM used in Taiwan; it will be tested as a treatment for liver...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Han Xiao | Chief Financial Officer |
| Han Xiao-Yan | Principal Financial Officer and Director |
| Wen Chao Zhang | Director of Scientific and Technological Development |
Ms. Han had five years of hygiene and medical media experience before joining TDR. She has been instrumental in developing and marketing TDR’s products and expanding its sales. She serves as a senior marketing manager and administrative manager and has 10 years of financial management experience. In 2004, she was appointed the general manager of TDR, with responsibility for financing, production, quality control and purchasing. In 2003, she was appointed director of Harbin First Bio-Engineering. She received Master of Business Administration at Harbin Industrial University in 2004. Ms. Han Xiao-yan owns 1,406,717 shares, 8.9% of outstanding shares.
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Principal Financial Officer and Director | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Director of Scientific and Technological Development | Current |
| Volume | 258,691 |
| Shares Outstanding | 16.6M |
| Market Cap | 300.5M |
| Year High | 19.11 |
| Year Low | 10.030 |
| Earnings Per Share | 2.19 |
| P/E Ratio | 8.2374 |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

